Guideline for the diagnosis and treatment of scabies in Japan (second edition)

Norihisa Ishii, Akihiko Asahina, Masayuki Amagai, Masafumi Iijima, Osamu Ishikawa, Hidekazu Imamura, Mariko Ooe, Noriko Ohtaki, Yasuhiko Kato, Nobuo Kanazawa, Ryoichi Kamide, Tamotsu Kanzaki, Akira Konohana, Masayo Komoda, Natsuko Sugiyama, Mari Sekine, Shinichiro Takezaki, Masaru Tanaka, Nobuko Tamura, Yuzuru NagaokaHiroko Nanko, Masayuki Hayashi, Kuniko Makigami, Tomoko Matsuda, Junko Yoshizumi, Yasuo Wada

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August 2006 under health insurance and its clinical use was expected to increase. For making a proper diagnosis, the following three points should be taken into consideration: (i) clinical symptoms; (ii) detection of the mite (Sarcoptes scabiei); and (iii) epidemiological symptoms. The diagnosis is confirmed if the mites or eggs are identified by microscopy or dermoscopy and so forth. Topical sulfur preparations, with only limited usefulness, are the only available topical drugs approved by health insurance coverage for treating scabies. Currently, crotamiton, benzyl benzoate and γ-benzene hexachloride are also used clinically. It is important to apply these to the whole-body, including hands, fingers and genitals. The dose for ivermectin is a single administration p.o. of approximately 200 μg/kg bodyweight with water before a meal. Administration of a second dose is considered, if new specific lesions develop or the mites are detected. For treating crusted scabies, concomitant administration of oral ivermectin and the topical preparation is necessary. Some safe and useful topical drug preparations are needed to be approved by health insurance.

Original languageEnglish
Pages (from-to)378-393
Number of pages16
JournalJournal of Dermatology
Volume35
Issue number6
DOIs
Publication statusPublished - 2008 Jun

Fingerprint

Scabies
Mites
Health Insurance
Ivermectin
Japan
Guidelines
Sarcoptes scabiei
Dermoscopy
Lindane
Drug Compounding
Insurance Coverage
Sulfur
Eggs
Fingers
Oral Administration
Meals
Microscopy
Therapeutics
Hand
Water

Keywords

  • Crotamiton
  • Crusted scabies
  • Dermoscopy
  • Guideline
  • Ivermectin
  • Scabies

ASJC Scopus subject areas

  • Dermatology

Cite this

Guideline for the diagnosis and treatment of scabies in Japan (second edition). / Ishii, Norihisa; Asahina, Akihiko; Amagai, Masayuki; Iijima, Masafumi; Ishikawa, Osamu; Imamura, Hidekazu; Ooe, Mariko; Ohtaki, Noriko; Kato, Yasuhiko; Kanazawa, Nobuo; Kamide, Ryoichi; Kanzaki, Tamotsu; Konohana, Akira; Komoda, Masayo; Sugiyama, Natsuko; Sekine, Mari; Takezaki, Shinichiro; Tanaka, Masaru; Tamura, Nobuko; Nagaoka, Yuzuru; Nanko, Hiroko; Hayashi, Masayuki; Makigami, Kuniko; Matsuda, Tomoko; Yoshizumi, Junko; Wada, Yasuo.

In: Journal of Dermatology, Vol. 35, No. 6, 06.2008, p. 378-393.

Research output: Contribution to journalArticle

Ishii, N, Asahina, A, Amagai, M, Iijima, M, Ishikawa, O, Imamura, H, Ooe, M, Ohtaki, N, Kato, Y, Kanazawa, N, Kamide, R, Kanzaki, T, Konohana, A, Komoda, M, Sugiyama, N, Sekine, M, Takezaki, S, Tanaka, M, Tamura, N, Nagaoka, Y, Nanko, H, Hayashi, M, Makigami, K, Matsuda, T, Yoshizumi, J & Wada, Y 2008, 'Guideline for the diagnosis and treatment of scabies in Japan (second edition)', Journal of Dermatology, vol. 35, no. 6, pp. 378-393. https://doi.org/10.1111/j.1346-8138.2008.00491.x
Ishii, Norihisa ; Asahina, Akihiko ; Amagai, Masayuki ; Iijima, Masafumi ; Ishikawa, Osamu ; Imamura, Hidekazu ; Ooe, Mariko ; Ohtaki, Noriko ; Kato, Yasuhiko ; Kanazawa, Nobuo ; Kamide, Ryoichi ; Kanzaki, Tamotsu ; Konohana, Akira ; Komoda, Masayo ; Sugiyama, Natsuko ; Sekine, Mari ; Takezaki, Shinichiro ; Tanaka, Masaru ; Tamura, Nobuko ; Nagaoka, Yuzuru ; Nanko, Hiroko ; Hayashi, Masayuki ; Makigami, Kuniko ; Matsuda, Tomoko ; Yoshizumi, Junko ; Wada, Yasuo. / Guideline for the diagnosis and treatment of scabies in Japan (second edition). In: Journal of Dermatology. 2008 ; Vol. 35, No. 6. pp. 378-393.
@article{001e7f72a3df424fa3fe893fbcc84305,
title = "Guideline for the diagnosis and treatment of scabies in Japan (second edition)",
abstract = "The guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August 2006 under health insurance and its clinical use was expected to increase. For making a proper diagnosis, the following three points should be taken into consideration: (i) clinical symptoms; (ii) detection of the mite (Sarcoptes scabiei); and (iii) epidemiological symptoms. The diagnosis is confirmed if the mites or eggs are identified by microscopy or dermoscopy and so forth. Topical sulfur preparations, with only limited usefulness, are the only available topical drugs approved by health insurance coverage for treating scabies. Currently, crotamiton, benzyl benzoate and γ-benzene hexachloride are also used clinically. It is important to apply these to the whole-body, including hands, fingers and genitals. The dose for ivermectin is a single administration p.o. of approximately 200 μg/kg bodyweight with water before a meal. Administration of a second dose is considered, if new specific lesions develop or the mites are detected. For treating crusted scabies, concomitant administration of oral ivermectin and the topical preparation is necessary. Some safe and useful topical drug preparations are needed to be approved by health insurance.",
keywords = "Crotamiton, Crusted scabies, Dermoscopy, Guideline, Ivermectin, Scabies",
author = "Norihisa Ishii and Akihiko Asahina and Masayuki Amagai and Masafumi Iijima and Osamu Ishikawa and Hidekazu Imamura and Mariko Ooe and Noriko Ohtaki and Yasuhiko Kato and Nobuo Kanazawa and Ryoichi Kamide and Tamotsu Kanzaki and Akira Konohana and Masayo Komoda and Natsuko Sugiyama and Mari Sekine and Shinichiro Takezaki and Masaru Tanaka and Nobuko Tamura and Yuzuru Nagaoka and Hiroko Nanko and Masayuki Hayashi and Kuniko Makigami and Tomoko Matsuda and Junko Yoshizumi and Yasuo Wada",
year = "2008",
month = "6",
doi = "10.1111/j.1346-8138.2008.00491.x",
language = "English",
volume = "35",
pages = "378--393",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Guideline for the diagnosis and treatment of scabies in Japan (second edition)

AU - Ishii, Norihisa

AU - Asahina, Akihiko

AU - Amagai, Masayuki

AU - Iijima, Masafumi

AU - Ishikawa, Osamu

AU - Imamura, Hidekazu

AU - Ooe, Mariko

AU - Ohtaki, Noriko

AU - Kato, Yasuhiko

AU - Kanazawa, Nobuo

AU - Kamide, Ryoichi

AU - Kanzaki, Tamotsu

AU - Konohana, Akira

AU - Komoda, Masayo

AU - Sugiyama, Natsuko

AU - Sekine, Mari

AU - Takezaki, Shinichiro

AU - Tanaka, Masaru

AU - Tamura, Nobuko

AU - Nagaoka, Yuzuru

AU - Nanko, Hiroko

AU - Hayashi, Masayuki

AU - Makigami, Kuniko

AU - Matsuda, Tomoko

AU - Yoshizumi, Junko

AU - Wada, Yasuo

PY - 2008/6

Y1 - 2008/6

N2 - The guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August 2006 under health insurance and its clinical use was expected to increase. For making a proper diagnosis, the following three points should be taken into consideration: (i) clinical symptoms; (ii) detection of the mite (Sarcoptes scabiei); and (iii) epidemiological symptoms. The diagnosis is confirmed if the mites or eggs are identified by microscopy or dermoscopy and so forth. Topical sulfur preparations, with only limited usefulness, are the only available topical drugs approved by health insurance coverage for treating scabies. Currently, crotamiton, benzyl benzoate and γ-benzene hexachloride are also used clinically. It is important to apply these to the whole-body, including hands, fingers and genitals. The dose for ivermectin is a single administration p.o. of approximately 200 μg/kg bodyweight with water before a meal. Administration of a second dose is considered, if new specific lesions develop or the mites are detected. For treating crusted scabies, concomitant administration of oral ivermectin and the topical preparation is necessary. Some safe and useful topical drug preparations are needed to be approved by health insurance.

AB - The guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August 2006 under health insurance and its clinical use was expected to increase. For making a proper diagnosis, the following three points should be taken into consideration: (i) clinical symptoms; (ii) detection of the mite (Sarcoptes scabiei); and (iii) epidemiological symptoms. The diagnosis is confirmed if the mites or eggs are identified by microscopy or dermoscopy and so forth. Topical sulfur preparations, with only limited usefulness, are the only available topical drugs approved by health insurance coverage for treating scabies. Currently, crotamiton, benzyl benzoate and γ-benzene hexachloride are also used clinically. It is important to apply these to the whole-body, including hands, fingers and genitals. The dose for ivermectin is a single administration p.o. of approximately 200 μg/kg bodyweight with water before a meal. Administration of a second dose is considered, if new specific lesions develop or the mites are detected. For treating crusted scabies, concomitant administration of oral ivermectin and the topical preparation is necessary. Some safe and useful topical drug preparations are needed to be approved by health insurance.

KW - Crotamiton

KW - Crusted scabies

KW - Dermoscopy

KW - Guideline

KW - Ivermectin

KW - Scabies

UR - http://www.scopus.com/inward/record.url?scp=45249093021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249093021&partnerID=8YFLogxK

U2 - 10.1111/j.1346-8138.2008.00491.x

DO - 10.1111/j.1346-8138.2008.00491.x

M3 - Article

C2 - 18578720

AN - SCOPUS:45249093021

VL - 35

SP - 378

EP - 393

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 6

ER -